These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 8968530

  • 1. Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system.
    Yamazaki M, Tokui T, Ishigami M, Sugiyama Y.
    Biopharm Drug Dispos; 1996 Dec; 17(9):775-89. PubMed ID: 8968530
    [Abstract] [Full Text] [Related]

  • 2. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro.
    Yamada T, Niinuma K, Lemaire M, Terasaki T, Sugiyama Y.
    Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591
    [Abstract] [Full Text] [Related]

  • 3. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
    Yamazaki M, Kobayashi K, Sugiyama Y.
    Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
    [Abstract] [Full Text] [Related]

  • 4. In vivo evidence for carrier-mediated uptake of beta-lactam antibiotics through organic anion transport systems in rat kidney and liver.
    Tsuji A, Terasaki T, Tamai I, Takeda K.
    J Pharmacol Exp Ther; 1990 Apr; 253(1):315-20. PubMed ID: 2329514
    [Abstract] [Full Text] [Related]

  • 5. Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin.
    Nezasa K, Higaki K, Takeuchi M, Nakano M, Koike M.
    Xenobiotica; 2003 Apr; 33(4):379-88. PubMed ID: 12745873
    [Abstract] [Full Text] [Related]

  • 6. Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.
    Nakai D, Nakagomi R, Furuta Y, Tokui T, Abe T, Ikeda T, Nishimura K.
    J Pharmacol Exp Ther; 2001 Jun; 297(3):861-7. PubMed ID: 11356905
    [Abstract] [Full Text] [Related]

  • 7. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
    Yamazaki M, Kobayashi K, Sugiyama Y.
    Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
    Badolo L, Bundgaard C, Garmer M, Jensen B.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):767-72. PubMed ID: 23648783
    [Abstract] [Full Text] [Related]

  • 10. Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.
    Yamazaki M, Akiyama S, Nishigaki R, Sugiyama Y.
    Pharm Res; 1996 Oct 16; 13(10):1559-64. PubMed ID: 8899851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier.
    Kikuchi R, Kusuhara H, Abe T, Endou H, Sugiyama Y.
    J Pharmacol Exp Ther; 2004 Dec 16; 311(3):1147-53. PubMed ID: 15292460
    [Abstract] [Full Text] [Related]

  • 13. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat.
    Sasabe H, Terasaki T, Tsuji A, Sugiyama Y.
    J Pharmacol Exp Ther; 1997 Jul 16; 282(1):162-71. PubMed ID: 9223551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
    Yamazaki M, Akiyama S, Ni'inuma K, Nishigaki R, Sugiyama Y.
    Drug Metab Dispos; 1997 Oct 16; 25(10):1123-9. PubMed ID: 9321514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Basolateral uptake of mercuric conjugates of N-acetylcysteine and cysteine in the kidney involves the organic anion transport system.
    Zalups RK.
    J Toxicol Environ Health A; 1998 Sep 11; 55(1):13-29. PubMed ID: 9747601
    [Abstract] [Full Text] [Related]

  • 18. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T, Kusuhara H, Maeda K, Kanamaru H, Saito Y, Hu Z, Sugiyama Y.
    Drug Metab Dispos; 2010 Feb 11; 38(2):215-22. PubMed ID: 19875501
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY, Okochi H, Huang Y, Benet LZ.
    Drug Metab Dispos; 2006 Jul 11; 34(7):1175-81. PubMed ID: 16624870
    [Abstract] [Full Text] [Related]

  • 20. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
    Gallicano KD, Buttar HS, Moffatt JH.
    Res Commun Chem Pathol Pharmacol; 1993 May 11; 80(2):163-74. PubMed ID: 8321920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.